Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01104207 · ClinicalTrials.gov registry record · Phase 1
Transcranial Magnetic Stimulation for Tinnitus
A Phase 1 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 1
- Development phase
- 70
- Enrollment target
NCT01104207: Completed Phase 1 study, sponsored by VA Office of Research and Development.
NCT01104207 is a Phase 1 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 70 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (17% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01104207, a Phase 1 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effectiveness of repetitive transcranial magnetic stimulation (rTMS) for reducing the loudness or severity of chronic tinnitus.
Primary Outcome
The TFI is a 25-item questionnaire that assesses tinnitus severity. The possible range of scores for the TFI is 0 to 100, with higher scores indicating more severe tinnitus.
Interventions
- DEVICE repetitive transcranial magnetic stimulation (rTMS)
- DEVICE placebo rTMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2011-03 |
| Est. Completion | 2016-12 |
| Phase | Phase 1 |
What the finished NCT01104207 record still lists
NCT01104207 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (17% higher).
The record links to 0 conditions, and to 2 interventions - of which repetitive transcranial magnetic stimulation (rTMS) is the first listed.
NCT01104207 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01104207 about?
NCT01104207 is a clinical study titled "Transcranial Magnetic Stimulation for Tinnitus". The purpose of this study is to assess the effectiveness of repetitive transcranial magnetic stimulation (rTMS) for reducing the loudness or severity of chronic tinnitus.
What is the current status of trial NCT01104207?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 70 participants. The study started on 2011-03. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01104207?
The interventions under investigation include: repetitive transcranial magnetic stimulation (rTMS) (DEVICE), placebo rTMS (DEVICE).
Who is sponsoring clinical trial NCT01104207?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01104207's enrollment target sits among peer trials
70 749th of 2000 higher than 1,227 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia